Advertisement

PharmacoEconomics & Outcomes News

, Volume 825, Issue 1, pp 2–2 | Cite as

ICER reports on esketamine, upadacitinib

News item
  • 7 Downloads

References

  1. 1.
    Institute for Clinical and Economic Review. ICER Releases Draft Evidence Report on Esketamine for Treatment-Resistant Depression. Internet Document : 21 Mar 2019. Available from: URL: https://icer-review.org/announcements/trd-draft-evidence-report/
  2. 2.
    Institute for Clinical and Economic Review. ICER to Assess Upadacitinib and Other Treatments for Rheumatoid Arthritis. Internet Document : 26 Mar 2019. Available from: URL: https://icer-review.org/announcements/icer-to-assess-upadacitinib-and-other-treatments-for-rheumatoid-arthritis/

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations